Kamada Net Cash Flow 2012-2025 | KMDA

Kamada net cash flow from 2012 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.

Kamada Net Cash Flow 2012-2025 | KMDA

Kamada net cash flow from 2012 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$218.1B
Amgen (AMGN)$157.3B
Gilead Sciences (GILD)$135.7B
Vertex Pharmaceuticals (VRTX)$119.2B
Bristol Myers Squibb (BMY)$94.5B
CSL (CSLLY)$78.8B
GSK (GSK)$77.4B
Regeneron Pharmaceuticals (REGN)$59.2B
Alnylam Pharmaceuticals (ALNY)$40.6B
Argenex SE (ARGX)$34B
BioNTech SE (BNTX)$26.6B
Royalty Pharma (RPRX)$20.5B
Insmed (INSM)$19.5B
Biogen (BIIB)$18.7B
Illumina (ILMN)$15.4B
Genmab (GNMSF)$14.2B
Genmab (GMAB)$13.6B
Incyte (INCY)$13.2B
Moderna (MRNA)$12.2B
Exelixis (EXEL)$12B
BioMarin Pharmaceutical (BMRN)$10.9B
Ascendis Pharma (ASND)$10.7B
QIAGEN (QGEN)$10.5B
Swedish Orphan Biovitrum (BIOVF)$10.4B
Exact Sciences (EXAS)$10B
Verona Pharma American Depositary Share (VRNA)$8.9B
Blueprint Medicines (BPMC)$8.4B
Bio-Techne Corp (TECH)$8.1B
Roivant Sciences (ROIV)$7.7B
Legend Biotech (LEGN)$7.3B